Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

Published:2015-01 Issue: Volume:37 Page:456-468
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Cai Liqiong,Xu Gaofei,Shi Changying,Guo Dandan,Wang Xu,Luo Juntao

Funder

NIH

NCI

Carol M. Baldwin Breast Cancer Research Foundation

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference38 articles.

1. Sequences of taxol and cisplatin: a phase I and pharmacologic study;Rowinsky;J Clin Oncol,1991

2. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine;Rowinsky;J Cancer Res Clin Oncol,1993

3. Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo;Milross;Int J Cancer,1995

4. Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha;Sacchi;Clin Cancer Res,2006

5. Latest research and treatment of advanced-stage epithelial ovarian cancer;Coleman;Nat Rev Clin Oncol,2013

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formation mechanism, prevention of malignant ascites effusion and reduction of intestinal mucosal irritation of natural microemulsion from Euphorbia lathyris Pulveratum;Biomedicine & Pharmacotherapy;2024-09

2. Synergistic effect of waste-derived β-tricalcium phosphate microbeads loaded in hydroxyapatite-keratin-polyvinyl alcohol composite matrix in drug release for osteosarcoma treatment;Future Journal of Pharmaceutical Sciences;2024-08-28

3. Advancements in dendrimer-based drug delivery for combinatorial cancer therapy;Journal of Drug Delivery Science and Technology;2024-08

4. Biomimetic “nano-spears” for CAFs-targeting: splintered three “shields” with enhanced cisplatin anti-TNBC efficiency;Journal of Controlled Release;2024-06

5. Current development of theragnostic nanoparticles for women’s cancer treatment;Biomedical Materials;2024-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3